When Gut Microbes Run Out of Fiber, Do They Start Digesting Your Gut Lining? What the New Mucus-Layer Research Shows

When dietary fiber is insufficient, gut microbes can switch their primary food source from plant-derived carbohydrates to the glycoproteins that make up the intestinal mucus layer — a shift that erodes the gut's first line of defense and alters the balance of metabolites circulating in the body. Two studies led by Ludwig Princeton's Jenna AbuSalim and Director Joshua Rabinowitz, published in PNAS and Nature Metabolism in 2026, have added significant new detail to this picture — including the discovery of a previously overlooked class of plant nutrients that can redirect microbial metabolism toward healthier outputs.

The table below compares the key findings across the major studies that have shaped our understanding of fiber deprivation and mucus degradation.

Study	Year / Journal	Key Finding	Model Used
Desai et al. (Martens/Desai lab)	2016 / Cell	Fiber deprivation thins colonic mucus layer; infection risk rises; 4 bacterial strains drive mucus erosion	Gnotobiotic mice with 14 defined human gut bacteria
Datta et al. (Ismagilov lab, Caltech)	2016 / PNAS	Dietary fiber compresses the mucus gel layer; bacteria and fiber interact dynamically to reshape mucus structure	Germ-free and conventional mice
AbuSalim, Rabinowitz et al. (Ludwig Princeton)	2026 / PNAS	Fiber + indigestible plant proteins ("Prif") shift phenol metabolites from harmful (tyrosine-derived) to beneficial (phenylalanine-derived); fiber suppresses bacterial consumption of host mucus proteins	Mouse gut isotope-tracing
AbuSalim, Rabinowitz et al. (Ludwig Princeton)	2026 / Nature Metabolism	Mammalian metabolism — not just gut microbes — independently produces many indole and phenol metabolites; antibiotic treatment confirms microbial vs. host origins	Mice, rats, human cells, cancer patient samples

What exactly happens to the gut lining when fiber runs out?

The gut mucus layer is a gel-like barrier secreted by goblet cells lining the colon, composed primarily of glycoproteins called mucins. It forms two distinct sublayers in the large intestine: a sterile inner layer that keeps bacteria away from the epithelial surface, and an outer layer where microbes and mucus coexist. This architecture is not static — mucus is continuously produced and degraded, and the balance between those two processes is heavily influenced by what gut bacteria are eating.

When fiber is abundant, bacteria have a preferred substrate: the complex carbohydrates in plant cell walls. When fiber disappears from the diet, certain bacterial species pivot. A landmark 2016 study published in Cell by Mahesh Desai, Eric Martens, and colleagues at the University of Michigan demonstrated this with unusual precision. The researchers used gnotobiotic mice — animals raised without any gut bacteria of their own — and transplanted a defined community of 14 bacterial species whose full genetic signatures were known. This setup allowed the team to track exactly which bacteria were active and which enzymes they were producing under different dietary conditions.

The result was stark. Mice fed a diet containing roughly 15% fiber from minimally processed grains and plants maintained a thick, protective mucus layer. When the researchers switched mice to a fiber-free diet — even for just a few days — some bacteria began eroding the mucus. Four bacterial strains that flourished most under low-fiber conditions were the only ones in the community capable of producing enzymes that break down glycoproteins. The team detected more than 1,600 enzymes capable of degrading carbohydrates, and the mix of enzymes shifted toward mucus-degrading variants as fiber dropped.

"The lesson we're learning from studying the interaction of fiber, gut microbes and the intestinal barrier system is that if you don't feed them, they can eat you," said Eric Martens, who led the research alongside Desai, as reported by Michigan Medicine.

Critically, a diet rich in purified prebiotic fiber — the kind found in many supplements and processed foods — produced a similar erosion of the mucus layer as the fiber-free diet. This suggests that fiber quality and diversity, not just fiber quantity, matters for maintaining the mucus barrier.

What did the 2026 Ludwig Princeton studies add to this picture?

The new research from AbuSalim and Rabinowitz goes several steps further, tracing not just the structural consequences of fiber deprivation but the precise metabolic pathways involved — and identifying a new dietary category that may be nearly as important as fiber itself.

The PNAS study used stable (non-radioactive) isotope labeling to follow proteins through the mouse gut and determine where specific metabolites originated. The researchers focused on phenol metabolites — compounds that gut bacteria produce when they process the amino acids tyrosine and phenylalanine. These metabolites are not all equivalent:

Phenylpropionate and hippuric acid are produced from phenylalanine and are associated with gut health and healthy body weight.
p-Cresol sulfate and phenol sulfate come from tyrosine and have been linked to worse outcomes in cancer patients and systemic toxicity in people with kidney disease.

The isotope tracing revealed that the harmful, tyrosine-derived phenols were produced when bacteria consumed proteins from the host — including proteins from the mucus lining of the gut. The beneficial phenols, by contrast, came almost entirely from dietary protein that reached the microbes undigested. This is a mechanistic confirmation of the mucus-eating hypothesis: fiber deprivation doesn't just thin the mucus layer structurally, it actively redirects microbial metabolism toward consuming host proteins and producing harmful byproducts.

"Our studies showed that both the fiber and indigestible proteins from plants — which we call 'proteins imitating fiber,' or Prif — shift the balance of phenol metabolites from the harmful kind made from tyrosine to the healthful variety derived from phenylalanine," said AbuSalim, as reported by ScienceDaily.

What are "Prif" — proteins imitating fiber — and why do they matter?

Prif is a class of indigestible plant proteins that resist breakdown in the upper gastrointestinal tract and reach the colon intact, where they become available to gut microbes. The concept is analogous to dietary fiber — indigestible plant carbohydrates that feed colonic bacteria — but applies to the protein fraction of plant foods.

This distinction matters because the standard nutritional framework treats plant protein as a digestible macronutrient absorbed in the small intestine. The Ludwig Princeton research shows that a meaningful fraction of plant protein escapes digestion and reaches the colon, where it shapes microbial metabolism in ways that parallel fiber's effects.

Fiber and Prif appear to work through complementary mechanisms. Fiber suppresses the bacterial breakdown of the gut's mucus lining — reducing the production of harmful phenols at the source. Prif increases the amount of dietary protein that reaches gut microbes, giving them an alternative substrate and steering them toward producing beneficial phenols from phenylalanine rather than harmful ones from host-derived tyrosine.

"We think Prifs represent an emerging class of dietary nutrients that shape the composition of the gut microbiome and could have a far-reaching influence on metabolic health," said AbuSalim. Rabinowitz added: "Food packaging may eventually list Prif right below fiber," according to ScienceDaily.

The practical implication is that whole plant foods — which contain both fiber and Prif — may confer gut health benefits that cannot be replicated by isolated fiber supplements alone. This aligns with the 2016 Michigan finding that purified prebiotic fiber failed to protect the mucus layer as effectively as fiber from minimally processed plant foods.

What are indole metabolites, and does the gut microbiome actually make them?

The Nature Metabolism study tackled a foundational assumption in microbiome research: that phenol and indole metabolites are produced exclusively by gut bacteria.

Indole metabolites are compounds derived from the amino acid tryptophan that have been linked to many physiological and pathological processes, including inflammatory bowel disease, neurodegenerative disorders, cancer metastasis, and anti-tumor immune responses. Researchers have been especially interested in dietary and probiotic strategies to raise beneficial indole metabolites like indole-3-lactate and indole-3-acetate.

Using isotope tracing in mice, rats, and human cells, AbuSalim, Rabinowitz, and colleagues found that mammalian metabolism can produce many of these indole and phenol metabolites independently of the microbiome. In mice, circulating levels of these metabolites remained high even after antibiotic treatment disrupted the gut microbiome — a pattern that also appeared in samples from cancer patients taking antibiotics. Metabolites made exclusively by microbes — including indole-3-propionate and p-cresol sulfate — declined after antibiotic treatment, as expected.

This finding has real consequences for therapeutic strategy. If a clinician or researcher is trying to raise indole-3-lactate levels through probiotics or dietary changes, they need to know whether the target metabolite is primarily microbial or primarily mammalian in origin. Interventions designed to boost microbial production of a compound that the body largely makes itself will be less effective — and may miss the actual regulatory lever.

How does the mucus layer actually protect the gut, and what happens when it degrades?

The gut epithelium is the single-cell-thick lining of the intestinal tract that separates the body's internal environment from the contents of the gut — including trillions of bacteria, undigested food particles, and potential pathogens. The mucus layer is the epithelium's primary physical defense.

Cleveland Clinic's overview of the gut microbiome notes that the gut microbiome includes over a thousand species of bacteria, as well as viruses, fungi, and parasites. Most of these microorganisms have a symbiotic relationship with their host — they receive food and shelter, and in return they perform essential functions including breaking down complex carbohydrates, synthesizing vitamins B1, B9, B12, and K, and producing short-chain fatty acids that feed the cells of the gut lining itself.

The mucus layer is what keeps this symbiosis from tipping into pathology. When it degrades, the physical distance between bacteria and the epithelial surface shrinks. The 2016 Michigan study demonstrated this consequence directly: mice on a fiber-free diet that were subsequently infected with Citrobacter rodentium — a bacterial strain that mimics what certain E. coli strains do in humans — showed far more severe illness than mice on a high-fiber diet. The dangerous bacteria flourished in the fiber-deprived gut, and many of the affected mice lost weight and showed signs of systemic illness.

The goblet cells that produce mucus are constantly working to replenish the layer, but under low-fiber conditions, bacteria degrade the mucus faster than it can be replaced — as Michigan Medicine described it, "almost like an overzealous harvesting of trees outpacing the planting of new ones."

Research from Caltech's Ismagilov lab added another dimension: dietary fiber doesn't just feed bacteria, it also physically compresses the mucus gel layer, making its pores smaller and harder for pathogens to penetrate. This effect was observed in mice fed diets rich in polymers including dietary fiber like pectin from apples. Germ-free mice showed even greater compression, suggesting that bacteria that break down fiber partially counteract this protective compression — a nuanced relationship between fiber, microbes, and mucus structure.

Which bacteria are most involved in mucus degradation?

The ISAPP podcast with Dr. Mindy Engevik from the Medical University of South Carolina provides useful context on the microbial side of this equation. Different bacterial species interact with mucus in different ways:

Bifidobacteria increase mucus production by goblet cells, reinforcing the protective layer.
Akkermansia muciniphila is unusual: it degrades mucus as a carbon source but simultaneously stimulates goblet cells to produce more mucus, maintaining a net-positive effect on barrier integrity under normal conditions.
Pathogens like Clostridioides difficile degrade mucus and suppress mucus production, creating a double hit on barrier integrity.

The four bacterial strains identified in the Michigan study as primary mucus degraders under fiber-deprived conditions are distinct from Akkermansia — they lack the compensatory mucus-stimulating effect. When fiber disappears, these strains proliferate and their mucus-degrading enzyme production increases, without a corresponding increase in mucus synthesis.

This bacterial specificity matters for probiotic and prebiotic strategies. Not all fiber-feeding bacteria are equivalent, and not all mucus-associated bacteria are harmful. Maintaining a community composition where fiber-fermenters dominate and mucus-degraders remain in check requires consistent dietary fiber input.

Does this mean fiber supplements are as good as whole-food fiber?

The evidence suggests they are not equivalent, at least for mucus protection. The 2016 Michigan study found that a diet rich in purified prebiotic fiber — the kind of soluble fiber found in many supplements — produced mucus erosion comparable to a fiber-free diet. This was one of the study's more counterintuitive findings, and it points to the importance of fiber diversity and food matrix.

Whole plant foods deliver fiber in a complex matrix alongside Prif (indigestible plant proteins), phytochemicals, and other compounds that collectively shape the microbiome. Isolated fiber supplements deliver a single type of fermentable substrate, which may selectively feed certain bacterial species without providing the full ecological support that a diverse plant-based diet offers.

The Ludwig Princeton research reinforces this interpretation. Prif and fiber appear to work synergistically: fiber suppresses mucus degradation, while Prif provides an alternative protein substrate that steers bacteria toward producing beneficial phenols. A supplement that delivers fiber without Prif captures only part of the mechanism.

This does not mean fiber supplements are without value — they have demonstrated benefits for cholesterol, blood sugar regulation, and stool consistency. But for the specific goal of protecting the mucus layer and optimizing microbial metabolite profiles, whole plant foods appear to be the more complete intervention.

What are the implications for disease prevention and therapy?

The combined findings from these studies have several practical implications that researchers are beginning to work through.

For kidney disease, the link between p-cresol sulfate — a tyrosine-derived phenol produced when bacteria consume host mucus proteins — and systemic toxicity in kidney disease patients is well established. The Ludwig Princeton research suggests that dietary fiber and Prif could reduce p-cresol sulfate production by redirecting microbial metabolism away from host proteins. This is a testable dietary intervention for a patient population where gut-kidney interactions are already a recognized therapeutic target.

For cancer, indole and phenol metabolites have been found to affect cancer metastasis and anti-tumor immune responses. The Nature Metabolism finding that many of these metabolites are produced by mammalian metabolism independently of the microbiome means that researchers need to reconsider which metabolites are actually responsive to microbiome-targeted interventions. Probiotic or dietary strategies designed to raise indole-3-lactate, for example, may have limited effect if the body is producing most of it anyway.

For inflammatory bowel disease, the mucus layer is already known to be compromised. The fiber-deprivation mechanism identified in these studies suggests that dietary fiber adequacy — and specifically, fiber from diverse whole plant sources rather than purified supplements — should be a priority in IBD management. The ISAPP podcast with Dr. Engevik notes that IBD is among the human diseases most clearly associated with a dysfunctional gut mucus layer.

For general metabolic health, the shift from harmful to beneficial phenol metabolites associated with plant-based diets — mediated by both fiber and Prif — offers a mechanistic explanation for some of the metabolic benefits of plant-forward eating patterns that go beyond simple caloric or macronutrient effects.

"Beyond that," said Rabinowitz, "a clearer picture of how different foods interact with the microbiome to modulate the production of bacterial metabolites will help sharpen the guidance nutritionists and doctors can give to people for disease prevention and therapy," according to ScienceDaily.

What should you actually eat to protect your gut lining?

The research does not yet translate into precise dietary prescriptions, but several evidence-based principles emerge from the combined body of work.

Prioritize fiber from minimally processed plant foods — whole grains, legumes, vegetables, and fruits — over purified fiber supplements. The 2016 Michigan data suggests that fiber diversity and food matrix matter for mucus protection in ways that isolated prebiotic fiber does not replicate.

Recognize that indigestible plant proteins (Prif) are a meaningful part of the gut health equation. Foods rich in plant protein — legumes, nuts, seeds, whole grains — deliver both fiber and Prif, making them doubly beneficial for microbial metabolism. The Ludwig Princeton team suggests that Prif content may eventually appear on food labels alongside fiber.

Maintain fiber intake consistently. Even brief periods of fiber deprivation — the Michigan study showed effects within days — can shift the bacterial community toward mucus-degrading activity. Occasional high-fiber days do not fully compensate for chronic low-fiber intake.

Be cautious about extrapolating microbiome research to supplement strategies. The Nature Metabolism finding that mammalian metabolism independently produces many indole and phenol metabolites means that the value of probiotic interventions targeting specific metabolites needs to be reassessed on a compound-by-compound basis.

For readers interested in related gut health topics, our guides on best probiotic capsules for bloating and IBS and best gas relief supplements cover the strain-level evidence for specific probiotic interventions in the Indian market.

What remains uncertain?

Several important questions remain open. The Ludwig Princeton studies were conducted primarily in mice, with some isotope tracing in human cells and patient samples. Whether the Prif mechanism operates at the same scale in humans eating varied diets is not yet established.

The identity and food sources of the most beneficial Prif are not fully characterized. The research establishes the category and its metabolic effects, but a practical guide to which plant foods deliver the most Prif — and in what quantities — does not yet exist.

The long-term clinical significance of the harmful phenol metabolites (p-cresol sulfate, phenol sulfate) in otherwise healthy people is also uncertain. The associations with worse cancer outcomes and kidney disease toxicity are established in those patient populations, but whether reducing these metabolites through diet translates into measurable health benefits for healthy adults remains an open question.

What is clear is that the gut mucus layer is not a passive structure — it is a dynamic interface shaped by diet, microbial community composition, and host metabolism, and it responds to changes in fiber intake faster than most people assume. The emerging science of Prif adds a new dimension to that picture, and the finding that mammalian metabolism contributes substantially to the metabolite pool attributed to gut microbes requires a fundamental recalibration of how researchers design and interpret microbiome intervention studies.

"There's growing interest across medical disciplines in manipulating the human microbiome or using its metabolic products themselves for therapy," said Rabinowitz. "Diet holds great promise for controlling the microbiome and its outputs. But to devise effective therapeutic interventions, we need to understand what aspects of the diet control which microbial outputs," as quoted by ScienceDaily.

The 2026 studies from Ludwig Princeton represent a significant step toward that understanding — and a reminder that the gut microbiome's relationship with its host is more metabolically intertwined, and more responsive to diet, than the field appreciated even a decade ago.